Prestige Wealth Management Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.9K | Buy |
331
+5
| +2% | +$391 | 0.01% | 324 |
|
|
2025
Q1 | $23.6K | Hold |
326
| – | – | 0.01% | 326 |
|
|
2024
Q4 | $24.1K | Sell |
326
-635
| -66% | -$47K | 0.01% | 334 |
|
|
2024
Q3 | $63.4K | Buy |
961
+92
| +11% | +$6.07K | 0.01% | 230 |
|
|
2024
Q2 | $80.3K | Hold |
869
| – | – | 0.02% | 188 |
|
|
2024
Q1 | $83K | Hold |
869
| – | – | 0.02% | 220 |
|
|
2023
Q4 | $66.3K | Sell |
869
-5
| -0.6% | -$381 | 0.02% | 221 |
|
|
2023
Q3 | $60.6K | Buy |
874
+4
| +0.5% | +$277 | 0.01% | 221 |
|
|
2023
Q2 | $82.1K | Hold |
870
| – | – | 0.02% | 223 |
|
|
2023
Q1 | $72K | Sell |
870
-19
| -2% | -$1.57K | 0.02% | 212 |
|
|
2022
Q4 | $66.3K | Sell |
889
-1,166
| -57% | -$87K | 0.02% | 230 |
|
|
2022
Q3 | $170K | Buy |
2,055
+112
| +6% | +$9.27K | 0.05% | 148 |
|
|
2022
Q2 | $184K | Buy |
1,943
+1,114
| +134% | +$105K | 0.05% | 138 |
|
|
2022
Q1 | $98K | Buy |
829
+200
| +32% | +$23.6K | 0.02% | 185 |
|
|
2021
Q4 | $81K | Buy |
629
+80
| +15% | +$10.3K | 0.02% | 221 |
|
|
2021
Q3 | $63K | Sell |
549
-100
| -15% | -$11.5K | 0.02% | 232 |
|
|
2021
Q2 | $67K | Hold |
649
| – | – | 0.02% | 217 |
|
|
2021
Q1 | $54K | Hold |
649
| – | – | 0.01% | 246 |
|
|
2020
Q4 | $59K | Buy |
649
+4
| +0.6% | +$364 | 0.02% | 230 |
|
|
2020
Q3 | $52K | Hold |
645
| – | – | 0.02% | 244 |
|
|
2020
Q2 | $44K | Sell |
645
-21
| -3% | -$1.43K | 0.02% | 237 |
|
|
2020
Q1 | $42K | Sell |
666
-837
| -56% | -$52.8K | 0.02% | 192 |
|
|
2019
Q4 | $117K | Buy |
1,503
+105
| +8% | +$8.17K | 0.06% | 150 |
|
|
2019
Q3 | $102K | Buy |
1,398
+345
| +33% | +$25.2K | 0.06% | 149 |
|
|
2019
Q2 | $65K | Buy |
1,053
+753
| +251% | +$46.5K | 0.04% | 180 |
|
|
2019
Q1 | $19K | Buy |
300
+204
| +213% | +$12.9K | 0.01% | 283 |
|
|
2018
Q4 | $5K | Buy |
+96
| New | +$5K | ﹤0.01% | 583 |
|